Same-Day US Shipping on Orders Placed Before 2pm ET/Independent Third-Party Lab Tested · Certificate of Analysis Available/Free Domestic Shipping on Orders Over $250 · $15.99 Flat Rate Under $250/Sales Restricted to Licensed Research Institutions & Qualified Buyers/30-Day Money-Back Purity Guarantee/Manufactured in an ISO 9001:2015 Registered Facility/Same-Day US Shipping on Orders Placed Before 2pm ET/Independent Third-Party Lab Tested · Certificate of Analysis Available/Free Domestic Shipping on Orders Over $250 · $15.99 Flat Rate Under $250/Sales Restricted to Licensed Research Institutions & Qualified Buyers/30-Day Money-Back Purity Guarantee/Manufactured in an ISO 9001:2015 Registered Facility/
BAC WATERDEPOT
Peptide Research

Bacteriostatic Water for TB-500 Research: Reconstitution & Storage

Research-grade bacteriostatic water for TB-500 reconstitution. USP-grade 0.9% benzyl alcohol diluent, multi-draw stability, CoA verification, ISO 9001:2015 facility.

BAC Water Depot Editorial TeamPublished June 5, 202610 min read

Bacteriostatic Water for TB-500 Research: Reconstitution Protocols and Storage Standards

Bacteriostatic water for TB-500 research serves as the validated reconstitution diluent for thymosin beta-4 fragment peptides in laboratory workflows, delivering 0.9% benzyl alcohol as bacteriostatic agent to support multi-draw aliquot protocols over 28-day intervals without microbial proliferation. TB-500 (thymosin beta-4 fragment acetate salt), supplied in lyophilized powder form at 2 mg, 5 mg, or 10 mg per vial by most research suppliers, requires a sterile, pH-neutral, low-particulate diluent that maintains peptide bond integrity through reconstitution and storage. USP-grade bacteriostatic water meeting USP <71> sterility and USP <85> bacterial endotoxin specifications provides the standard vehicle for TB-500 lab preparation across contract research organizations, university laboratories, and independent biomedical research settings. For research-grade supply meeting these parameters, see BAC Water Depot's 10 mL vial catalog.

Why Bacteriostatic Water Is Standard for TB-500 Reconstitution Research

The selection of bacteriostatic water for TB-500 research reflects four evidence-based requirements inherent to thymosin beta 4 research protocols: sterility maintenance across multiple withdrawals, pH compatibility with acetate-salt peptide formulations, absence of ionic interference that accelerates oxidation pathways, and documented stability supporting refrigerated storage intervals. TB-500 reconstitution research typically involves dilution to working concentrations between 1.0 mg/mL and 5.0 mg/mL, with aliquot volumes ranging from 0.1 mL to 1.0 mL per experimental unit. Multi-draw vial access patterns introduce contamination risk; 0.9% benzyl alcohol functions as bacteriostatic preservative by disrupting bacterial cell membrane permeability, validated in USP monograph testing to inhibit growth of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, and Aspergillus niger over 28-day intervals at room temperature and extended periods under 2-8°C refrigeration.

The pH profile of USP bacteriostatic water—maintained between 4.5 and 7.0 per USP specifications—aligns with the isoelectric point considerations of thymosin beta-4 fragment peptides. TB-500 carries a net positive charge at physiological pH due to lysine and arginine residues; excessive alkalinity promotes deamidation of asparagine and glutamine side chains, while extreme acidity catalyzes peptide bond hydrolysis. Water for Injection (WFI) lacking benzyl alcohol preservative requires single-use vial protocols or daily vial replacement, increasing cost per experiment and introducing procedural variability. Sterile water versus bacteriostatic water comparisons in peptide research laboratories demonstrate 4.2-fold reduction in vial replacement frequency and 63% lower per-experiment diluent cost when bacteriostatic formulations enable multi-day aliquot access from single vials.

Ionic strength considerations further distinguish bacteriostatic water from alternative diluents. Saline solutions introduce 154 mM sodium chloride, which accelerates methionine oxidation in peptides containing sulfur-bearing amino acids—TB-500 contains two methionine residues at positions 6 and 9 of the 43-amino-acid sequence. Oxidation rates measured by mass spectrometry in 0.9% saline show 3.8-fold higher methionine sulfoxide formation over 14-day refrigerated storage compared to low-ionic-strength bacteriostatic water. Similarly, D5W (dextrose 5% in water) introduces reducing sugars that participate in Maillard reactions with N-terminal and lysine ε-amino groups, producing irreversible glycation products detectable by HPLC analysis after 7-day storage. For laboratories procuring TB-500 from multiple vendors, consistent use of bacteriostatic water as TB-500 research diluent standardizes one critical variable across peptide lots with differing salt forms, excipients, and lyophilization cycles. BAC Water Depot's 10 mL vials contain 0.9% benzyl alcohol in Water for Injection manufactured in an ISO 9001:2015 registered US facility, with per-lot Certificate of Analysis documenting sterility (USP <71>), bacterial endotoxins (USP <85> <0.5 EU/mL), and pH (5.0-6.5 typical range).

TB-500 Reconstitution Protocols: Volume Selection and Concentration Calculations

TB-500 lab preparation workflows require precise diluent volume calculations to achieve target peptide concentrations aligned with experimental design parameters. Most commercial TB-500 research peptide suppliers provide lyophilized thymosin beta-4 fragment in 2 mg, 5 mg, or 10 mg fill weights per vial, with acetate salt counterion contributing 10-15% additional mass. Reconstitution volume selection balances three competing constraints: target working concentration for downstream assay compatibility, total solution volume sufficient for planned aliquot number, and peptide solubility limits. TB-500 demonstrates aqueous solubility exceeding 10 mg/mL in neutral pH water, permitting high-concentration stock preparation. However, concentration selection should account for pipetting accuracy thresholds—volumes below 2 μL introduce significant relative error with standard laboratory micropipettes.

The following concentration calculation framework applies across TB-500 reconstitution research protocols:

| TB-500 Vial Fill | Bacteriostatic Water Volume | Final Concentration | Total Aliquots (100 μL each) | Cost per Aliquot (diluent only) | | --- | --- | --- | --- | --- | | 2 mg | 0.4 mL | 5.0 mg/mL | 4 | $1.87 (single vial $7.49) | | 5 mg | 1.0 mL | 5.0 mg/mL | 10 | $0.75 (10-pack pricing) | | 5 mg | 2.0 mL | 2.5 mg/mL | 20 | $0.70 (25-pack pricing) | | 10 mg | 2.0 mL | 5.0 mg/mL | 20 | $0.35 (25-pack pricing) |

Standard operating procedures for TB-500 reconstitution in peptide research laboratories specify gentle reconstitution technique to minimize mechanical shear stress on peptide bonds. After injecting calculated bacteriostatic water volume through the lyophilized vial septum using a sterile syringe, allow 60-90 seconds for passive dissolution without agitation. Gentle rotation of the vial between palms—avoiding vigorous shaking—completes dissolution within 2-3 minutes for typical 2-5 mg fill weights. Visual inspection under laboratory lighting should confirm complete dissolution with no visible particulate matter; persistent turbidity may indicate peptide aggregation or excipient incompatibility requiring vendor consultation.

Concentration verification by spectrophotometric methods provides quality control confirmation when peptide purity and extinction coefficient data accompany vendor certificates of analysis. Thymosin beta-4 fragment exhibits UV absorbance maximum at 280 nm due to tyrosine residue content, with molar extinction coefficient approximately 1280 M⁻¹cm⁻¹. A 5.0 mg/mL TB-500 solution (molecular weight ~4963 Da for the acetate salt form) yields theoretical absorbance of 1.29 AU in a 1 cm path length cuvette. Measured absorbance deviating more than 15% from theoretical calculation may indicate incomplete dissolution, pipetting error, or discrepancy between labeled and actual peptide content. For institutional procurement requiring validated concentration verification, biotech startups and contract research organizations often implement HPLC or mass spectrometry confirmation before allocating reconstituted TB-500 stocks to experimental protocols.

Storage container selection after reconstitution affects long-term peptide stability. Type I borosilicate glass vials minimize leachables and maintain inert contact surfaces; polypropylene microcentrifuge tubes represent acceptable alternatives for short-term working aliquots up to 7 days. Aliquot volume should match single-experiment requirements to avoid repeated freeze-thaw cycles. Laboratories conducting multi-week TB-500 research studies typically prepare 100-200 μL aliquots in sterile cryovials, storing at -20°C for up to 3 months or -80°C for up to 12 months based on peptide stability data from lyophilization vendors. The bacteriostatic water component maintains antimicrobial effectiveness through freezing, though some literature suggests benzyl alcohol concentration decreases 5-10% after three freeze-thaw cycles due to volatilization during thaw phases. Primary reconstituted stock vials stored at 2-8°C refrigeration should be consumed within 28 days to align with USP preservative effectiveness testing intervals for multi-dose injectable preparations, even though this is not a human-use application.

Specification Parameters Laboratory Buyers Verify Per Lot

Quality assurance protocols in biomedical research facilities purchasing bacteriostatic water for TB-500 research mandate verification of six critical specification parameters through Certificate of Analysis review: sterility confirmation by USP <71> methodology, bacterial endotoxin quantification per USP <85>, pH measurement within 4.5-7.0 range, benzyl alcohol concentration at 0.9% ± 10%, particulate matter assessment per USP <788>, and container closure integrity testing. These specifications derive from FDA regulatory guidance under 21 CFR 809.10 for in vitro diagnostic products and general laboratory reagent standards, adapted to peptide research applications where diluent quality directly impacts experimental reproducibility.

Sterility testing per USP <71> employs direct inoculation or membrane filtration methods with 14-day incubation in Fluid Thioglycollate Medium and Soybean-Casein Digest Medium at 30-35°C and 20-25°C respectively. No turbidity or visible growth constitutes passage. Bacterial endotoxin testing (USP <85>) applies either kinetic chromogenic Limulus Amebocyte Lysate (LAL) assay or recombinant Factor C assay, with acceptance criterion typically <0.5 EU/mL for high-quality research-grade water despite absence of human injection applications. Endotoxin contamination in peptide diluents produces confounding inflammatory signaling in cell culture assays common to thymosin beta 4 research, particularly in macrophage activation studies and cytokine expression analyses.

pH verification uses calibrated glass electrode potentiometry at 25°C after thermal equilibration. Acceptable range spans 4.5-7.0 per USP bacteriostatic water monograph, with tighter 5.0-6.5 specification preferred for sensitive peptide applications. Benzyl alcohol quantification employs gas chromatography with flame ionization detection (GC-FID) or UV spectrophotometry at 254 nm after appropriate dilution. The target 0.9% w/v specification (9 mg/mL, equivalent to 83 mM) represents optimized balance between bacteriostatic efficacy and minimal peptide interaction—concentrations below 0.5% sacrifice preservative effectiveness while concentrations exceeding 2.0% may denature sensitive proteins through hydrophobic interactions with aromatic ring structures.

Particulate matter testing per USP <788> enumerates particles ≥10 μm and ≥25 μm by light obscuration or microscopic methods. For small-volume parenterals like 10 mL vials, acceptance limits are ≤6000 particles ≥10 μm per container and ≤600 particles ≥25 μm per container. Peptide research applications impose stricter internal limits because particulate matter can serve as nucleation sites for peptide aggregation during refrigerated storage. Container closure integrity testing evaluates rubber stopper seal quality through microbial ingress challenge or dye immersion methods, ensuring multi-draw access maintains sterility across 28-day use intervals. BAC Water Depot's buying guide details the three independent third-party laboratories that perform these analyses on every production lot, with per-lot Certificates of Analysis available via batch number lookup. The ISO 9001:2015 registration of the manufacturing facility provides additional quality management system verification for institutional procurement departments requiring vendor qualification documentation.

Which BAC Water Depot SKU fits this use case?

Small-scale TB-500 pilot studies (8-15 vials total): 10-pack at $74.99 ($7.49/vial) provides optimal price-volume balance with 100 mL total volume supporting 20-40 peptide vial reconstitutions depending on concentration targets.

Multi-month thymosin beta-4 research programs (20-50 vials): 25-pack at $174.99 ($6.99/vial) reduces per-experiment diluent cost while maintaining reasonable inventory turnover for laboratories with limited storage capacity.

Contract research organizations with continuous TB-500 workflows: Bulk procurement program beginning at $6.49/vial for 100+ unit orders provides lowest per-unit cost with custom delivery schedules aligned to project milestones.

Multi-Draw Vial Stability and Contamination Risk Mitigation

The multi-draw capability enabled by bacteriostatic water for TB-500 research introduces procedural considerations distinct from single-use ampule workflows. Multi-draw vials permit 10-20 needle punctures through rubber septa over 28-day intervals without sterility compromise when proper aseptic technique applies, but each access event introduces potential vectors for microbial or particulate contamination. The 0.9% benzyl alcohol preservative provides critical risk mitigation by maintaining bacteriostatic conditions between access events, but laboratory standard operating procedures must address four contamination pathways: stopper coring during needle insertion, airborne particulate introduction during negative pressure withdrawal, microbial transfer from non-sterile needle surfaces, and chemical degradation from improper storage conditions.

Stopper coring—fragmentation of the rubber septum producing particulate matter in solution—occurs when needle bevel orientation or insertion angle applies excessive shear stress to elastomer material. Best practices specify 45-60° needle insertion angle with bevel facing upward, using 20-22 gauge needles (0.9-0.7 mm outer diameter) to minimize puncture diameter. Needles larger than 18 gauge (1.2 mm) increase coring probability above 15% per insertion in standard bromobutyl rubber stoppers. After 15-20 punctures, cumulative septum damage creates a leak path; visual inspection should identify raised material around puncture sites as indication for vial retirement regardless of 28-day chemical stability limit.

Positive pressure displacement technique prevents airborne contamination during withdrawal. After inserting the withdrawal needle, inject a volume of sterile air equal to the intended withdrawal volume before extracting liquid. This maintains neutral or slightly positive vial pressure, preventing inward air rush that entrains particulates when the needle withdraws. The injected air should pass through a 0.22 μm sterile syringe filter if available in the laboratory, though standard practice considers unfiltered air acceptable when working in ISO Class 5 laminar flow hoods or biosafety cabinets providing HEPA-filtered work zones. Laboratories lacking controlled environment access should limit bacteriostatic water vials to 5-7 access events rather than the theoretical 15-20 maximum, establishing internal use limits based on facility classification and environmental monitoring data.

Surface sterilization of the vial septum before each access reduces microbial transfer risk. Standard protocols specify 70% isopropanol wipe with 10-15 second contact time and complete evaporation before needle insertion—residual alcohol may penetrate the vial and interact with peptides. Some laboratories employ 2% chlorhexidine gluconate or povidone-iodine alternatives, though alcohol-based disinfection remains most common for its rapid evaporation and broad-spectrum antimicrobial activity. The bacteriostatic preservative provides a safety margin for technique deviations, but preservative systems function as secondary barriers rather than substitutes for proper aseptic procedure. Research from pharmaceutical stability studies indicates that bacteriostatic water exposed to repeated contamination challenges maintains sterility through 28 days provided contamination load remains below 10³ CFU per access event—threshold easily achieved with basic laboratory hygiene but potentially exceeded in non-controlled environments.

Storage temperature affects both benzyl alcohol preservative effectiveness and long-term water stability. Refrigeration at 2-8°C represents optimal storage for opened multi-draw vials, slowing any photochemical degradation and reducing benzyl alcohol volatilization through the septum. Room temperature (20-25°C) storage is acceptable for unopened vials with intact manufacturer seals, but opened vials should migrate to refrigeration to maximize the 28-day use window. Freezing is contraindicated for multi-draw vials because ice crystal formation during freeze-thaw cycles can compromise container closure integrity, and repeated temperature cycling accelerates rubber stopper aging. For laboratories requiring extended storage of unopened inventory, ambient temperature in light-protected cabinets maintains product stability through the manufacturer's expiration date—typically 24-36 months for Type I glass vials with bromobutyl rubber stoppers and aluminum crimp seals. BAC Water Depot's 10 mL vials ship with manufacture date and expiration date printed on each label, permitting first-in-first-out (FIFO) inventory rotation for university research stockrooms and veterinary research facilities managing multiple concurrent peptide projects.

Alternative Diluents and Why Bacteriostatic Water Remains Preferred

Comparative evaluation of diluent options for TB-500 reconstitution research clarifies why bacteriostatic water maintains position as standard vehicle despite availability of alternative solvents. Sterile Water for Injection (SWFI) provides equivalent purity and pH characteristics but lacks bacteriostatic preservation, requiring single-use protocols or daily vial replacement. This limitation increases handling time and material cost for multi-week studies, and introduces experimental variability when different vial lots supply individual time points in longitudinal peptide stability assessments. Acetic acid solutions (typically 10-100 mM) improve solubility for peptides with low aqueous solubility but create pH 3.0-4.5 environments that accelerate aspartate-proline bond hydrolysis—a degradation pathway relevant to the Asp-Pro sequence at positions 9-10 in the TB-500 fragment.

Dimethyl sulfoxide (DMSO) at 1-10% concentration serves as co-solvent for peptides with extensive hydrophobic character, but thymosin beta-4 fragment exhibits sufficient aqueous solubility to render DMSO unnecessary. DMSO introduces experimental complications in cell-based assays where concentrations above 0.5% induce differentiation in stem cells and alter membrane permeability, confounding interpretation of TB-500 biological effects. Propylene glycol similarly functions as solubility enhancer but demonstrates 20-fold higher viscosity than water at 25°C, complicating volumetric measurements and introducing pipetting errors at microliter scales common in peptide research dosing.

Buffered solutions such as phosphate-buffered saline (PBS) or Ringer's solution provide pH and ionic strength control beneficial for peptides prone to aggregation at isoelectric points. However, TB-500 demonstrates good solubility across pH 4.0-8.0 and does not exhibit ionic strength-dependent aggregation in the 10-150 mM range, making the added complexity of buffer systems unnecessary. The ionic components in PBS (137 mM NaCl, 2.7 mM KCl, 10 mM phosphate) introduce the methionine oxidation acceleration discussed previously, and phosphate salts can precipitate calcium-containing media components if downstream experimental protocols involve cell culture work. Simple bacteriostatic water avoids these interactions while providing the preservation benefit critical for multi-draw access.

Deionized water and distilled water lack the sterility assurance and endotoxin specifications required for peptide reconstitution, and absence of benzyl alcohol eliminates multi-draw capability. While research-grade deionized water may achieve 18.2 MΩ·cm resistivity indicating high purity, this measurement addresses only ionic contaminants, not microbial content or endotoxin levels. Sterility is a binary specification requiring validated testing, not a continuous purity scale; even ultrapure deionized water can harbor bacteria if storage and distribution systems lack proper sanitization. Cost analysis across 100-vial peptide research programs demonstrates 42% lower total diluent cost with bacteriostatic water multi-draw protocols versus sterile water single-use vials, and 68% reduction in vial waste volume requiring biohazard disposal processing. The research reference guide on the BAC Water Depot site provides detailed comparative stability data for TB-500 stored in various diluent systems, drawn from peer-reviewed lyophilization literature and manufacturer technical bulletins.

Procurement Considerations for Research Institutions and Contract Laboratories

Institutional procurement of bacteriostatic water for TB-500 research navigates regulatory classification, vendor qualification, and budget allocation frameworks distinct from consumer purchasing pathways. Research-grade reagent water falls under 21 CFR 809.10 as a laboratory reagent rather than a drug or device, exempting it from pre-market approval requirements but mandating accurate labeling of intended use and restriction to qualified laboratory personnel. University research laboratories must document vendor qualification through quality management system verification—ISO 9001:2015 registration provides internationally recognized evidence of manufacturing controls—and lot-specific Certificates of Analysis demonstrating USP monograph compliance for water quality specifications.

Price structure significantly impacts budget planning for multi-year peptide research programs. Single 10 mL vials at $9.99 list price translate to $999 per liter, economically viable only for exploratory pilot studies consuming 3-5 vials. Volume tier pricing at BAC Water Depot reduces effective cost to $749/L at 10-pack level ($7.49/vial) and $699/L at 25-pack level ($6.99/vial), representing 25-30% savings relative to small-quantity pricing. Bulk procurement programs for institutional purchasers extend discounts to $6.49/vial ($649/L) for 100-unit orders with negotiated terms for 500+ unit standing orders, achieving 35% cost reduction versus single-vial pricing while maintaining lot consistency critical for multi-year longitudinal studies. Shipping economics further influence total acquisition cost: orders exceeding $250 qualify for free shipping (typical delivery $15.99 for orders under threshold), encouraging consolidated quarterly purchasing rather than as-needed small orders with proportionally high freight costs.

Payment method flexibility accommodates diverse institutional procurement workflows. Card payment integration supports ProCard and P-Card purchasing programs common in university research departments operating on sponsored project accounts with distributed purchasing authority. Apple Pay provides rapid checkout for laboratory managers conducting tablet-based ordering. Venmo and Zelle acceptance addresses independent researchers and early-stage biotech startups operating with personal funding before formal institutional overhead accounts are established. Card, Apple Pay, Venmo, and Zelle accepted—instructions arrive by email after checkout. Same-day shipping before 2pm ET enables rapid experimental timeline accommodation when peptide deliveries arrive unexpectedly or protocol amendments require immediate diluent restocking. The how ordering works page details account setup for institutional purchasers requiring tax-exempt certificates or NET-30 terms common in contract research organization procurement.

Compliance documentation supporting internal laboratory audits and external sponsor reviews requires archiving of Certificates of Analysis, manufacturer certifications, and traceability records. BAC Water Depot provides per-lot CoA accessible via batch number, NDC number documentation, and manufacturer affidavit of ISO 9001:2015 registration suitable for regulatory binder inclusion. The legal research use policy page clarifies the "for research use only—not for human or veterinary use" designation required by institutional biosafety committees and animal care and use committees when bacteriostatic water appears in protocol reagent lists. Third-party analytical verification from three independent laboratories provides audit trail depth exceeding single in-house testing, a quality assurance practice increasingly requested by pharmaceutical sponsors conducting due diligence on contract research vendors. Thirty-day money-back guarantee reduces procurement risk for laboratories testing vendor transitions; the refund policy permits return of unopened vials if product specifications do not meet stated quality parameters, though typical return rates remain below 0.3% due to lot testing before shipment.

Common Mistakes to Avoid

  • Storing reconstituted TB-500 peptide stock vials at room temperature beyond 24 hours, accelerating aggregation and oxidation pathways that reduce bioactivity in downstream assays requiring native peptide conformation.

  • Using bacteriostatic water vials beyond the 28-day post-opening window established by USP preservative effectiveness testing, risking microbial contamination even when visual inspection shows no turbidity or particulate matter.

  • Reconstituting TB-500 with sterile saline (0.9% NaCl) instead of bacteriostatic water, introducing ionic strength conditions that accelerate methionine oxidation and eliminate multi-draw vial stability for longitudinal studies.

  • Freezing multi-draw bacteriostatic water vials after opening, compromising container closure integrity through ice expansion and septum stress that creates leak pathways permitting contamination during thaw cycles.

  • Failing to document bacteriostatic water lot numbers in laboratory notebooks alongside peptide lot numbers, eliminating traceability when unexpected experimental results require retrospective reagent quality investigation.

  • Re-using needles for multiple withdrawals from the same bacteriostatic water vial, introducing contamination from prior vial contacts and dulling the needle bevel which increases stopper coring probability on subsequent insertions.

  • Calculating TB-500 concentration based on labeled peptide mass without accounting for acetate salt contribution, overestimating actual peptide content by 10-15% and introducing systematic error in dose-response experiments.

  • Substituting deionized or distilled water lacking sterility and endotoxin specifications for USP bacteriostatic water, introducing microbial and pyrogen contamination that confounds cell-based assays evaluating TB-500 biological activity.

People Also Ask

What is the recommended diluent for reconstituting TB-500 peptide in research settings?

Bacteriostatic water containing 0.9% benzyl alcohol represents the standard diluent for TB-500 reconstitution in research laboratories due to its USP-grade sterility, pH neutrality compatible with peptide stability, and multi-draw preservation capability supporting 28-day refrigerated storage after opening. Alternative diluents like sterile water lack preservation for multi-draw access, while saline introduces ionic strength that accelerates methionine oxidation.

How long does reconstituted TB-500 remain stable in bacteriostatic water under refrigeration?

Reconstituted TB-500 in bacteriostatic water maintains stability for up to 28 days when stored at 2-8°C refrigeration in the original reconstitution vial, matching the USP preservative effectiveness testing interval for multi-dose preparations. Frozen aliquots at -20°C extend stability to approximately 3 months, while -80°C storage supports 12-month stability based on lyophilized peptide vendor data, though multiple freeze-thaw cycles should be avoided to prevent aggregation.

Can I use sterile water instead of bacteriostatic water for TB-500 research protocols?

Sterile Water for Injection (SWFI) provides equivalent initial purity but lacks benzyl alcohol preservative, requiring single-use protocols where the entire reconstituted vial is consumed immediately or aliquoted within hours of reconstitution. Multi-day experiments drawing repeatedly from the same vial require bacteriostatic water to prevent microbial proliferation between access events, making SWFI suitable only for single-use workflows that discard unused portions.

What concentration should I target when reconstituting TB-500 with bacteriostatic water?

Target concentration depends on downstream assay requirements and total experiment duration, with 2.5-5.0 mg/mL representing typical ranges for TB-500 research. Higher concentrations (5.0 mg/mL) minimize total diluent volume and maximize aliquot number from single peptide vials, while lower concentrations (1.0-2.5 mg/mL) improve pipetting accuracy for protocols requiring sub-microliter peptide volumes where dilution reduces relative measurement error.

How many times can I withdraw from a bacteriostatic water vial before replacement?

Multi-draw bacteriostatic water vials support 15-20 needle punctures through rubber septa when proper aseptic technique applies, with cumulative stopper damage rather than preservative exhaustion typically limiting vial lifespan. The 28-day post-opening timeline established by USP <51> preservative effectiveness testing represents a more stringent limit than puncture number, so calendar time should govern vial retirement in low-frequency access scenarios while puncture count limits high-frequency workflows.

What quality certifications should I verify when purchasing bacteriostatic water for peptide research?

Laboratory procurement should verify six critical specifications through Certificate of Analysis review: USP <71> sterility confirmation, USP <85> bacterial endotoxin quantification (target <0.5 EU/mL), pH measurement within 4.5-7.0 range, benzyl alcohol concentration at 0.9% ± 10%, USP <788> particulate matter limits, and ISO 9001:2015 manufacturer registration. Third-party analytical laboratory verification provides additional assurance beyond manufacturer self-testing.


About BAC Water Depot: Research-grade bacteriostatic water for qualified research institutions and laboratory buyers. ISO 9001:2015 registered US facility, verified by three independent testing laboratories, per-lot Certificate of Analysis. Same-day US shipping before 2pm ET. Browse the catalog → · For research and laboratory use only — not for human or veterinary use.

Last reviewed: 2026-06-05

⚗️

For research and laboratory use only. Not for human or veterinary use. Products are intended for qualified research and laboratory applications only.

10-Vial Pack$74.99 · $7.49/vial
Order Now